About Technology Issues FAQ

Links

Official Page

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma

Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.